跳至主要内容
临床试验/ACTRN12621000512820
ACTRN12621000512820招募中未知

SUpporting Mothers Milk Intervention Trial comparing different doses of domperidone for treating lactation insufficiency in mothers of preterm infants: A Follow-Up study (Post-SUMMIT)

South Australian Health and Medical Research Institute (SAHMRI)0 个研究点目标入组 110 人开始时间: 2021年5月3日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • All women who participated in the SUMMIT trial will be invited to participate. Selection criteria for SUMMIT include:
  • -Mothers of preterm infants born <34 weeks' gestation (up to 33+6)
  • -Lactation insufficiency defined as breast milk volume less than 300 mL/day in previous 24 hours if between 7 and 13 days postpartum, or breast milk volume less than 500 mL/day in previous 24 hours if between 14 and 28 days postpartum
  • -Between 7 and 28 days postpartum
  • -Expressing with an electric pump an average of 6 times a day or more in previous 24-48 hours
  • -Willing and able to comply with all study requirements, including treatment, timing and/or nature of required assessment and follow-up of mother and baby until infant discharge.
  • -Signed and written consent.

排除标准

  • - Did not participate in SUMMIT RCT

研究者

发起方
South Australian Health and Medical Research Institute (SAHMRI)

相似试验